5Von Pawel J. The role of topotecan in treating small cell lung cancer: Seeond-line treatment. Lung Cancer, 2003, 41 ( suppl4 ) : S3.
6Noda K, Nishiwaki Y, Kawahara M, et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin fbr ex-1 9. Tensive small ceil lung cancer [ J ]. N End J Med,2002,346 : 85.
7Jeremic B, Shibamoto Y, Acimovic L, et al. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent, chemothempy in limited small-cell lung cancer: A randomized study[ J]. J Clin Oncol, 1997,15:893.
8Sandier A, Gray R, Perry MC, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer[ J]. N Engl J Med,2006,355:2542-2550.
9Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis [ J ]. J Clin Oncol, 1992,10 : 890-895.
10/ Pignon Jp, Arriagada R, Ihde DC, et al. A meta-analysis of thq racic radiotherapy for small-cell lung cancer [ J ]. N Ensll / Med, 1992,327 : 1618-1624.
2Shiozaki H,Oka H,Inoue M,et al.E-cadherin mediated adhesion system in cancer cells.Cancer,1996,77(8 suppl)1605-1613.
3Salon C,Lantuejoul S,Eymin B,et al.The E-cadherin-beta-catenin complex and its implication in lung cancer progression and prognosis.Future Oncol,2005,1 (5):649-660.
4Dworakowska D.Clinical significance of PCNA expression in non-small cell lung cancer.Pneumonol Alergol Pol,2005,73(3):292-296.
5Sheneber A,Shibate H,Sampalis A,et al.Prognostic significance of proliferating cell nuclear antinen experssion in colorectal cancer.Cancer,1993,21(3):170.
6Kaihara T,Kusaka T,Kawamata H,et al.Decreased expression of E-cadherin and Yamamoto-Kohama's mode of invasion highly correlates with lymph node metastasis in esophageal squamous cell carcinom.Pathobiology,2001,69(3):172 -178.
8Van Rens MT,de la Riviere AB,Elbers HR,et al. Prognostic assessment of 2361 patients who underwent pulmonary resection for non-small cell lung cancer, stage Ⅰ,Ⅱ, and Ⅲ A [J]. Chest, 2000,117:374.
9Liberman M, Liberman D,Sampalis JS,et al. Delays to surgery in non-small-cell lung cancer [J].Can J Surg, 2006,49 ( 1 ) : 31 -36.
10Billing JS, Wells FC. Delays in the diagnoses and surgical treatment of lung cancer[J]. Thorax, 1996,51 (9) :903 -906.
1Therasse P,Arbuck SG,Eisenhauer EA,et al. New guidelines to e- valuate the response to treatment in solid tumors[ J]. J N Can Ins, 2000,92 ( 3 ) :205-216.
2Ferraldeschi R, Baka S, Jyoti B, et al. Modem management of small-cell lung cancer[J]. Drugs,2007,67 ( 15 ) :2135-2152.
3Ebert W, Muley T, Trainer C, et al. Comparision of changes in the NSE levels with clinical assessment in the therapy monitoring of patients with SCLC [J].Auti Cancer Res, 2002,22 (28) : 1083.
4Sarkaria IS, Stojadinovic A, Talbot SG. Squamous cell carcinoma- related oncogene is highly expressed in developing normal and ade- nomatous adrenal tissue but not in aggressive adrenocortical carci- nomas [ J ]. Surgery, 2004,136 (6) : 1122-1128.
